Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BINARYBIO

Financiado

Cerrado

Commercialization of distributed cloud solutions for biomolecular simulation a...

Commercialization of distributed cloud solutions for biomolecular simulation and free energy calculation "Computational chemistry is playing an increasingly important role for research in the pharmaceutical industry, oils & plastic, and materials development. Simulation and high-throughput screening can be orders of magnitude cheaper... ver más

31/07/2013

SERENDIPITY INNOVA...

137K€

Presupuesto del proyecto: 137K€

Líder del proyecto

SERENDIPITY INNOVATIONS AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-07-31 No tenemos la información de la convocatoria

0% 89% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

SERENDIPITY INNOVATIONS

0.00€ | Lider

BinaryBio

39.15K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ERIKLINDAHLERC2007 Multiscale and Distributed Computing Algorithms for Biomolec... 992K€ Cerrado

EQC2019-005580-P Recursos Computacionales basados en GPUs para Dinámica Molec... 48K€ Cerrado

Cloud-HTMD A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USI... 75K€ Cerrado

HTMD Feasibility assessment of a cloud application platform for r... 71K€ Cerrado

KvasirAccelerator The first utility-oriented, agnostic software platform for q... 4M€ Cerrado

ScalaLife Scalable Software Services for Life Science 4M€ Cerrado

Líder del proyecto

SERENDIPITY INNOVATIONS AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 137K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Computational chemistry is playing an increasingly important role for research in the pharmaceutical industry, oils & plastic, and materials development. Simulation and high-throughput screening can be orders of magnitude cheaper than experiments in the early stages of drug design. The ERC project preceding this application has developed several new techniques that make it orders-of-magnitude more efficient to calculate free energies from simulations rather than approximate docking screening. We have already had great academic success, but the requirement of large computer clusters or access to the Folding@Home network makes it difficult to implement in industry. To address this, we have developed a new framework for peer-to-peer distributed computing combined with Markov state models (called Copernicus) to be presented at Supercomputing’11. Copernicus completely removes the need to deal with single simulations, and allows users to specify workflows - directly on their laptop - in terms of free energy calculations or sampling of complex processes such as protein folding. Workflows are transparently uploaded to a server and split into distributed calculation workunits (e.g. in a company), computer clusters, but also cloud computing to deal with peaks in usage. The results are again transparently moved to the user’s machine. This provides a clear competitive advantage in terms of efficiency, and it removes all investment and support costs related to high-performance computing. This is of course not limited to molecular simulation, and in addition to the pharmaceutical track we want to investigate usage in the financial industry. We have just submitted a patent application for the dynamic data flow network that makes the peer-to-peer usage possible, but we would need a programmer to turn the research-level code into a working proof-of-concept for high-throughput screening applications in the pharmaceutical industry and another person to work on business development."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores